1. Home
  2. PSTV vs AMST Comparison

PSTV vs AMST Comparison

Compare PSTV & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • AMST
  • Stock Information
  • Founded
  • PSTV 1996
  • AMST 2017
  • Country
  • PSTV United States
  • AMST United States
  • Employees
  • PSTV N/A
  • AMST N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • AMST Computer Software: Prepackaged Software
  • Sector
  • PSTV Health Care
  • AMST Technology
  • Exchange
  • PSTV Nasdaq
  • AMST Nasdaq
  • Market Cap
  • PSTV 10.4M
  • AMST 9.5M
  • IPO Year
  • PSTV N/A
  • AMST 2020
  • Fundamental
  • Price
  • PSTV $0.18
  • AMST $2.63
  • Analyst Decision
  • PSTV Strong Buy
  • AMST
  • Analyst Count
  • PSTV 3
  • AMST 0
  • Target Price
  • PSTV $13.00
  • AMST N/A
  • AVG Volume (30 Days)
  • PSTV 13.6M
  • AMST 52.9K
  • Earning Date
  • PSTV 08-13-2025
  • AMST 05-15-2025
  • Dividend Yield
  • PSTV N/A
  • AMST N/A
  • EPS Growth
  • PSTV N/A
  • AMST N/A
  • EPS
  • PSTV N/A
  • AMST N/A
  • Revenue
  • PSTV $5,206,000.00
  • AMST $82,544.00
  • Revenue This Year
  • PSTV $13.26
  • AMST N/A
  • Revenue Next Year
  • PSTV $8.84
  • AMST N/A
  • P/E Ratio
  • PSTV N/A
  • AMST N/A
  • Revenue Growth
  • PSTV N/A
  • AMST N/A
  • 52 Week Low
  • PSTV $0.16
  • AMST $2.00
  • 52 Week High
  • PSTV $2.31
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 29.61
  • AMST 43.83
  • Support Level
  • PSTV $0.16
  • AMST $2.67
  • Resistance Level
  • PSTV $0.36
  • AMST $3.02
  • Average True Range (ATR)
  • PSTV 0.04
  • AMST 0.16
  • MACD
  • PSTV -0.00
  • AMST -0.05
  • Stochastic Oscillator
  • PSTV 8.38
  • AMST 8.89

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: